203 related articles for article (PubMed ID: 25866142)
21. Interleukin-6 production by the blast cells of acute myeloblastic leukemia: regulation by endogenous interleukin-1 and biological implications.
Beauchemin V; Villeneuve L; Rodriguez-Cimadevilla JC; Rajotte D; Kenney JS; Clark SC; Hoang T
J Cell Physiol; 1991 Sep; 148(3):353-61. PubMed ID: 1918169
[TBL] [Abstract][Full Text] [Related]
22. Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia.
Bruserud O; Tore Gjertsen B; Brustugun OT; Bassøe CF; Nesthus I; Espen Akselsen P; Bühring HJ; Pawelec G
Leukemia; 1995 Nov; 9(11):1910-20. PubMed ID: 7475283
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
24. Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia.
Mansour I; Zayed RA; Said F; Latif LA
Hematology; 2016 Sep; 21(8):447-53. PubMed ID: 27077762
[TBL] [Abstract][Full Text] [Related]
25. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
[TBL] [Abstract][Full Text] [Related]
26. Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts.
Bruserud Ø; Ryningen A; Wergeland L; Glenjen NI; Gjertsen BT
Haematologica; 2004 Apr; 89(4):391-402. PubMed ID: 15075072
[TBL] [Abstract][Full Text] [Related]
27. Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients.
Govindaraj C; Tan P; Walker P; Wei A; Spencer A; Plebanski M
Clin Cancer Res; 2014 Feb; 20(3):724-35. PubMed ID: 24297862
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway.
Xu Y; Mou J; Wang Y; Zhou W; Rao Q; Xing H; Tian Z; Tang K; Wang M; Wang J
Leukemia; 2022 Feb; 36(2):403-415. PubMed ID: 34381181
[TBL] [Abstract][Full Text] [Related]
29. In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22.
Olsnes AM; Ryningen A; Ersvaer E; Bruserud Ø
J Interferon Cytokine Res; 2008 May; 28(5):297-310. PubMed ID: 18547160
[TBL] [Abstract][Full Text] [Related]
30. In vitro culture of acute myelogenous leukemia blasts: a comparison of four different culture media.
Bruserud O; Frostad S; Foss B
J Hematother; 1999 Feb; 8(1):63-73. PubMed ID: 10192303
[TBL] [Abstract][Full Text] [Related]
31. PD-L1 Is Expressed and Promotes the Expansion of Regulatory T Cells in Acute Myeloid Leukemia.
Dong Y; Han Y; Huang Y; Jiang S; Huang Z; Chen R; Yu Z; Yu K; Zhang S
Front Immunol; 2020; 11():1710. PubMed ID: 32849603
[TBL] [Abstract][Full Text] [Related]
32. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
[TBL] [Abstract][Full Text] [Related]
33. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
34. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
35. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of T cell activation markers and upregulation of Tregs in bone marrow and peripheral blood in acute myeloid leukemia patients.
Fang J; Zhang R; Lin X; Xu Y; Huang K; Saw PE
Hematology; 2023 Dec; 28(1):2219554. PubMed ID: 37288810
[TBL] [Abstract][Full Text] [Related]
37. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
[TBL] [Abstract][Full Text] [Related]
38. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
39. Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice.
Ferretti E; Montagna D; Di Carlo E; Cocco C; Ribatti D; Ognio E; Sorrentino C; Lisini D; Bertaina A; Locatelli F; Pistoia V; Airoldi I
Leukemia; 2012 Feb; 26(2):225-35. PubMed ID: 21844875
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM
Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]